Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biotechnology Companies in 2026
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.
  1. ATAI Life Sciences N.V.

    World Rank (Aug-2026)
    5,361
    Market Cap (Aug-2026)
    2.692 Billion USD
    World Rank (Jan-05-2024)
    16,036
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    15,102
    Market Cap (Jul-30-2023)
    0.342 Billion USD
    World Rank (Dec-25-2022)
    13,197
    Market Cap (Dec-25-2022)
    0.443 Billion USD
    World Rank (Jan-07-2022)
    9,233
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Headquarters Country
    Company Profile
    Atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.
  2. Bloomage Biotechnology Corporation

    World Rank (Aug-2026)
    5,385
    Market Cap (Aug-2026)
    2.674 Billion USD
    World Rank (Jan-05-2024)
    3,258
    Market Cap (Jan-05-2024)
    4.378 Billion USD
    World Rank (Jul-30-2023)
    2,357
    Market Cap (Jul-30-2023)
    6.534 Billion USD
    World Rank (Dec-25-2022)
    1,682
    Market Cap (Dec-25-2022)
    8.940 Billion USD
    World Rank (Jan-07-2022)
    1,814
    Market Cap (Jan-07-2022)
    10.44 Billion USD
    Annual Revenue in USD
    891 Million USD
    Annual Operating Income in USD
    156 Million USD
    Annual Net Income in USD
    136 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Bloomage Biotechnology Corporation is a Biotechnology and Bioactive Material company. It is having nearly 200 specifications of pharmaceutical grade, cosmetic grade and food grade products which are widely used in the fields of medicines, medical devices, cosmetics and functional foods. The headquarters is in China.
  3. Portola Pharmaceuticals

    World Rank (Aug-2026)
    5,432
    World Rank (Jan-05-2024)
    5,432
    World Rank (Jul-30-2023)
    5,432
    World Rank (Dec-25-2022)
    5,432
    World Rank (Jan-07-2022)
    5,432
    Annual Revenue in USD
    117 Million USD
    Annual Operating Income in USD
    -271 Million USD
    Annual Net Income in USD
    -291 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    Company Profile

    Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.

  4. Trevi Therapeutics

    World Rank (Aug-2026)
    5,440
    Market Cap (Aug-2026)
    2.630 Billion USD
    World Rank (Jan-05-2024)
    22,095
    Market Cap (Jan-05-2024)
    0.088 Billion USD
    World Rank (Jul-30-2023)
    20,000
    Market Cap (Jul-30-2023)
    0.138 Billion USD
    World Rank (Dec-25-2022)
    21,267
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    21,111
    Annual Operating Income in USD
    -49 Million USD
    Annual Net Income in USD
    -43 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Trevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.

  5. Axogen

    World Rank (Aug-2026)
    5,456
    Market Cap (Aug-2026)
    2.620 Billion USD
    World Rank (Jan-05-2024)
    15,954
    Market Cap (Jan-05-2024)
    0.291 Billion USD
    World Rank (Jul-30-2023)
    14,713
    Market Cap (Jul-30-2023)
    0.365 Billion USD
    World Rank (Dec-25-2022)
    13,575
    Market Cap (Dec-25-2022)
    0.420 Billion USD
    World Rank (Jan-07-2022)
    14,686
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    225 Million USD
    Annual Operating Income in USD
    -8 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Axogen is a company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The headquarters is in USA.
    Facts About Company
    Axogen company annual revenue was 138 million USD and annual net loss was -28 million USD as on Dec-2022.
  6. Ultragenyx Pharmaceutical

    World Rank (Aug-2026)
    5,466
    Market Cap (Aug-2026)
    2.612 Billion USD
    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    673 Million USD
    Annual Operating Income in USD
    -535 Million USD
    Annual Net Income in USD
    -575 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

  7. Kodiak Sciences

    World Rank (Aug-2026)
    5,488
    Market Cap (Aug-2026)
    2.588 Billion USD
    World Rank (Jan-05-2024)
    19,085
    Market Cap (Jan-05-2024)
    0.160 Billion USD
    World Rank (Jul-30-2023)
    19,561
    Market Cap (Jul-30-2023)
    0.150 Billion USD
    World Rank (Dec-25-2022)
    14,429
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    4,108
    Market Cap (Jan-07-2022)
    3.74 Billion USD
    Annual Operating Income in USD
    -234 Million USD
    Annual Net Income in USD
    -230 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

  8. SELLAS Life Sciences Group

    World Rank (Aug-2026)
    5,497
    Market Cap (Aug-2026)
    2.581 Billion USD
    World Rank (Jan-05-2024)
    27,339
    Market Cap (Jan-05-2024)
    0.029 Billion USD
    World Rank (Jul-30-2023)
    25,548
    Market Cap (Jul-30-2023)
    0.047 Billion USD
    World Rank (Dec-25-2022)
    25,573
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    23,258
    Market Cap (Jan-07-2022)
    0.09 Billion USD
    Annual Operating Income in USD
    -28 Million USD
    Annual Net Income in USD
    -27 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  9. Viela Bio

    World Rank (Aug-2026)
    5,505
    World Rank (Jan-05-2024)
    5,505
    World Rank (Jul-30-2023)
    5,505
    World Rank (Dec-25-2022)
    5,505
    World Rank (Jan-07-2022)
    5,505
    Annual Revenue in USD
    12 Million USD
    Annual Operating Income in USD
    -154 Million USD
    Annual Net Income in USD
    -151 Million USD
    Annual Results for Period Ending
    For year ending December-2020
    Headquarters Country
    Company Profile

    Viela Bio is a Biotechnology company. It is dedicated to the development and commercialization of novel, life changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. The headquarters is in USA.

    Horizon Therapeutics acquired Viela Bio in 2021 for 3 billion USD.

    Facts About Company

    As on Sep 2020, they have 166 employees.

  10. Neogen Corporation

    World Rank (Aug-2026)
    5,559
    Market Cap (Aug-2026)
    2.540 Billion USD
    World Rank (Jan-05-2024)
    3,352
    Market Cap (Jan-05-2024)
    4.227 Billion USD
    World Rank (Jul-30-2023)
    2,981
    Market Cap (Jul-30-2023)
    4.993 Billion USD
    World Rank (Dec-25-2022)
    3,893
    Market Cap (Dec-25-2022)
    3.214 Billion USD
    World Rank (Jan-07-2022)
    3,668
    Market Cap (Jan-07-2022)
    4.31 Billion USD
    Annual Revenue in USD
    870 Million USD
    Annual Operating Income in USD
    -22 Million USD
    Annual Net Income in USD
    -8 Million USD
    Annual Results for Period Ending
    For year ending May-2026
    Headquarters Country
    Company Profile

    Neogen Corporation is a Food Processing, Animal Protein and Agriculture Industries company. It serve the companion and performance animal industries as well as the fields of life sciences and toxicology. The headquarters is in USA.

Share

Ads